Option Care Health to be taken private in $5.8 billion deal with McKesson and CD&R
Option Care Health announced an agreement with McKesson Corp. and private‑equity firm Clayton Dubilier & Rice to be taken private. The buyers will pay $32.05 in cash per share, valuing the company at roughly $5.8 billion. The transaction splits ownership 49% to McKesson and 51% to CD&R and is slated to close in the first half of 2027 pending approvals.
Why it matters
Option Care shareholders will receive a cash payment of $32.05 per share, representing about a 37% premium to the prior close, which should lock in immediate value. The deal will delist OPCH and give McKesson a foothold in the home‑infusion market, potentially enhancing its specialty‑drug distribution strategy. Completion depends on shareholder and regulatory approvals, so timing remains uncertain.
Key facts
- 1Option Care Health agreed to be taken private for $32.05 per share in cash. benzinga.com
- 2The transaction values the company at about $5.8 billion enterprise value. benzinga.com
- 3The offer represents roughly a 37% premium to Option Care’s October 5 closing price of $23.37. benzinga.com
- 4McKesson will invest about $1.4 billion for a 49% equity stake, while CD&R will hold about 51%. benzinga.com
- 5The deal is expected to close in the first half of 2027, subject to shareholder and regulatory approvals. benzinga.com
- 6At the time of announcement, Option Care shares were trading around $31.05, leaving about a $1.00 spread to the deal price. benzinga.com
Summary written by AlphAI from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.